These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2813232)

  • 1. Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease.
    Hendra TJ; Baguley E; Harris EN; Khamashta MH; Trembath RC; Hughes GR; Yudkin JS
    Postgrad Med J; 1989 Mar; 65(761):140-3. PubMed ID: 2813232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
    Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
    Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies are no marker for survived myocardial infarction.
    Eber B; Kronberger-Schaffer E; Brussee H; Klima G; Obernosterer A; Toporsch M; Dusleag J; Klein W
    Klin Wochenschr; 1990 Jun; 68(12):594-6. PubMed ID: 2376955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anticardiolipin antibodies in the elderly British population.
    Chakravarty KK; Gray RE; Webley M; Byron MA; Wozniak J
    Postgrad Med J; 1991 Apr; 67(786):358-61. PubMed ID: 2068029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies.
    Sairam S; Baethge BA; McNearney T
    Clin Rheumatol; 2003 Feb; 22(1):24-9. PubMed ID: 12605313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticardiolipin antibodies and early infarct of the myocardium].
    Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
    Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes.
    Cronin ME; Biswas RM; Van der Straeton C; Fleisher TA; Klippel JH
    J Rheumatol; 1988; 15(5):795-8. PubMed ID: 3172093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies are associated with cognitive dysfunction in stroke-free individuals.
    Homayoon N; Schwingenschuh P; Hofer E; Katschnig-Winter P; Schmidt R
    Eur J Neurol; 2014 Mar; 21(3):427-32, e21-2. PubMed ID: 24313894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease.
    Marai I; Shechter M; Langevitz P; Gilburd B; Rubenstein A; Matssura E; Sherer Y; Shoenfeld Y
    Am J Cardiol; 2008 Apr; 101(8):1094-7. PubMed ID: 18394439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late thrombotic events in patients with temporal arteritis and anticardiolipin antibodies.
    Cid MC; Cervera R; Font J; Lopez-Soto A; Pallarés L; Navarro M; Ingelmo M
    Clin Exp Rheumatol; 1990; 8(4):359-63. PubMed ID: 2397625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibody: a marker of immune reactivity.
    Hoppmann RA; Loeser R; Saluta G; Rothberger H
    Clin Exp Rheumatol; 1989; 7(3):283-6. PubMed ID: 2788057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke.
    Sletnes KE; Smith P; Abdelnoor M; Arnesen H; Wisløff F
    Lancet; 1992 Feb; 339(8791):451-3. PubMed ID: 1346819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG-anticardiolipin-antibodies are markers for cerebral and peripheral artery disease.
    Friehs I; Eber B; Friehs G; Langsteger W; Koch G
    Vasa; 1992; 21(2):158-62. PubMed ID: 1621434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibody positivity in diabetic patients with and without diabetic foot.
    Alagözlü H; Bakici Z; Gültekin F; Yildirim B; Sezer H
    J Diabetes Complications; 2002; 16(2):172-5. PubMed ID: 12039401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cardiolipin antibodies in ischaemic heart disease.
    Klemp P; Cooper RC; Strauss FJ; Jordaan ER; Przybojewski JZ; Nel N
    Clin Exp Immunol; 1988 Nov; 74(2):254-7. PubMed ID: 3224444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticardiolipin antibodies in diffuse connective tissue diseases with IgG, IgM and IgA isotypes].
    Hrncír Z; Chýlková V
    Vnitr Lek; 1990 Nov; 36(11):1041-9. PubMed ID: 2267732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome.
    Pennec YL; Magadur G; Jouquan J; Youinou P
    Clin Exp Rheumatol; 1991; 9(2):165-7. PubMed ID: 2060162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis.
    Shinzato MM; Bueno C; Trindade Viana VS; Borba EF; Gonçalves CR; Bonfá E
    Lupus; 2005; 14(12):953-8. PubMed ID: 16425575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
    Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
    Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.